Involvement of oxidative stress in NF-κB activation in endothelial cells treated by photodynamic therapy

Photochemistry and Photobiology

Volumn 75, Issue 1, 2002, Pages 36-45

  Volanti, Cédric ^a   Matroule, Jean Yves ^a   Piette, Jacques ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CYTOKINE; FLUORESCENT DYE; HERBIMYCIN A; I KAPPA B; I KAPPA B ALPHA; I KAPPA B BETA; I KAPPA B EPSILON; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; ISOTOPE; PHORBOL DERIVATIVE; PHOTOSENSITIZING AGENT; PROTEIN P100; PROTEIN P105; PROTEIN TYROSINE KINASE; PYROPHEOPHORBIDE A METHYL ESTER; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; UNCLASSIFIED DRUG; CHUK PROTEIN, HUMAN; DNA BINDING PROTEIN; IKBKB PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PORPHYRIN; PROTEIN SERINE THREONINE KINASE; PYROPHEOPHORBIDE A METHYLESTER; PYROPHEOPHORBIDE-A METHYLESTER;

AMINO ACID SEQUENCE; ARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PROTEIN DEGRADATION; REPORTER GENE; TRANSCRIPTION INITIATION; BIOLOGY; CELL CULTURE; CELL LINE; CHEMISTRY; DRUG EFFECT; METABOLISM; PHOTOCHEMOTHERAPY; VASCULAR ENDOTHELIUM;

CELL LINE; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; NF-KAPPA B; OXIDATIVE STRESS; PHOTOBIOLOGY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0036363622     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2002)075<0036:IOOSIN>2.0.CO;2     Document Type: Article

References (49)

1. Yancopoulos, G. D., S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand and J. Holash (2000) Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248.
2. Stevens, T., J. G. Garcia, D. M. Shasby, J. Bhattacharya and A. B. Malik (2000) Mechanisms regulating endothelial cell barrier function. Am. J. Physiol. Lung Cell. Mol. Physiol. 279. L419-L422.
3. Wort, S. J. and T. W. Evans (1999) The role of the endothelium in modulating vascular control in sepsis and related conditions. Br. Med. Bull. 55, 30-48.
4. Colasanti, M. and H. Suzuki (2000) The dual personality of NO. Trends Pharmacol. Sci. 21. 249-252.
5. Masaki, T., S. Miwa, T. Sawamura, H. Ninomiya and Y. Okamoto (1999) Subcellular mechanisms of endothelin action in vascular system. Eur. J. Pharmacol. 375, 133-138.
6. Madri, J. A. and D. Graesser (2000) Cell migration in the immune system: the evolving inter-related roles of adhesion molecules and proteinases. Dev. Immunol. 7, 103-116.
7. Pearson, J. D. (1999) Endothelial cell function and thrombosis. Bailliere's Best Pract. Res. Clin. Haematol. 12, 329-341.
8. Andreasen, P. A., R. Egelund and H. H. Petersen (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci. 57, 25-40.
9. Kohler, H. P. and P. J. Grant (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease. N. Engl. J. Med. 342, 1792-1801.
10. Gross, P. L. and W. C. Aird (2000) The endothelium and thrombosis. Semin. Thromb. Hemost. 26, 463-478.
11. Ruoslahti, E. and D. Rajotte (2000) An address system in the vasculature of normal tissues and tumors. Annu. Rev. Immunol. 18, 813-827.
12. Irani, K. (2000) Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87, 179-183.
13. Henderson, B. W., L. Vaughan, D. A. Bellnier, H. van Leengoed, P. G. Johnson and A. R. Oseroff (1995) Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin. Photochem. Photobiol. 62, 780-789.
14. Schmidt-Erfurth, U. (1999) Indocyanine green angiography and retinal sensitivity after photodynamic therapy of subfoveal choroidal neovascularization. Semin. Ophthalmol. 14, 35-44.
15. Moor, A. C. (2000) Signaling pathways in cell death and survival after photodynamic therapy. J. Photochem. Photobiol. B 57, 1-13.
16. Hunt, D. W. and A. H. Chan (2000) Influence of photodynamic therapy on immunological aspects of disease - an update. Expert. Opin. Investig. Drugs. 9, 807-817.
17. Ell, C. and L. Gossner (2000) Photodynamic therapy. Recent Results Cancer Res. 155, 175-181.
18. Schmidt-Erfurth, U. and T. Hasan (2000) Mechanisms of Action of Photodynamic Therapy with Verteporfin for the Treatment of Age-Related Macular Degeneration. Surv. Ophthalmol. 45, 195-214.
19. Karin, M. (1999) The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J. Biol. Chem. 274, 27339-27342.
20. Karin, M. and M. Delhase (2000) The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol. 12, 85-98.
21. Mercurio, F. and A. M. Manning (1999) Multiple signals converging on NF-kappaB. Curr. Opin. Cell. Biol. 11, 226-232.
22. Ray, P., D. H. Zhang, J. A. Elias and A. Ray (1995) Cloning of a differentially expressed I kappa B-related protein. J. Biol. Chem. 270, 10680-10685.
23. Schmid, R. M. and G. Adler (2000) NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases. Gastroenterology 118, 1208-1228.
24. Karin, M. (1999) How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18, 6867-6874.
25. Traenckner, E. B., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk and P. A. Baeuerle (1995) Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14, 2876-2883.
26. Karin, M. and Y. Ben-Neriah (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immmunol. 18, 621-663.
27. Schoonbroodt, S., V. Ferreira, M. Best-Belpomme, J. R. Boelaert, S. Legrand-Poels, M. Korner and J. Piette (2000) Crucial role of the amino-terminal tyrosine residue 42 and the carboxylterminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress. J. Immunol. 164, 4292-4300.
28. Legrand-Poels, S., L. Zecchinon, B. Piret, S. Schoonbroodt and J. Piette (1997) Involvement of different transduction pathways in NF-kappa B activation by several inducers. Free Radic. Res. 27, 301-309.
29. Matroule, J. Y., G. Bonizzi, P. Morliere, N. Paillous, R. Santus, V. Bours and J. Piette (1999) Pyropheophorbide-a methyl estermediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway. J. Biol. Chem. 274, 2988-3000.
30. Schuitmaker, J. J., B. M. de Koster and J. G. Elferink (1998) The effects of photodynamic therapy on human neutrophil migration using bacteriochlorin a. Photochem. Photobiol. 68, 841-845.
31. Schoonbroodt, S. and J. Piette (2000) Oxidative stress interference with the nuclear factor- kappaB activation pathways. Biochem. Pharmacol. 60, 1075-1083.
32. Redmond, R. W., K. Heihoff, S. E. Braslavsky and T. G. Truscott (1987) Thermal-lensing and phosphorescence studies of the quantum yield and lifetime of singlet molecular oxygen (1 delta g) sensitized by hematoporphyrin and related porphyrins in deuterated and non-deuterated ethanols. Photochem. Photobiol. 45, 209-213.
33. Hassan, T. and J. A. Parrish (1997) Photodynamic therapy of cancer. In Cancer Medicine (Edited by J. F. Holland), pp. 739-751. Williams and Wilkins, Baltimore, MD.
34. Henderson, B. W. and T. J. Dougherty (1992) How does photodynamic therapy work? Photochem. Photobiol. 55, 145-157.
35. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G, Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng (1998) Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905.
36. Levy, J. G. (1995) Photodynamic therapy. Trends in Biotechnol. 13, 14-18.
37. Ryter, S. W. and C. J. Gomer (1993) Nuclear factor kappa B binding activity in mouse L1210 cells following photofrin II-mediated photosensitization. Photochem Photobiol. 58(5), 753-756.
38. Granville, D. J., C. M. Carthy, H. Jiang, J. G. Levy, B. M. McManus, J. Y. Matroule, J. Piette and D. W. Hunt (2000) Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin. Blood 95(1), 256-262.
39. Bonizzi, G., E. Dejardin, B. Piret, J. Piette, M. P. Merville and V. Bours (1996) Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediates. Eur. J. Biochem. 242, 544-549.
40. Bonizzi, G., J. Piette, M. P. Merville and V. Bours (1997) Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells. J. Immunol. 159, 5264-5272.
41. Bonizzi, G., J. Piette, S. Schoonbroodt, R. Greimers, L. Havard, M. P. Merville and V. Bours (1999) Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1 beta requires 5-lipoxygenase or NADPH oxidase activity. Mol. Cell. Biol. 19, 1950-1960.
42. Matroule, J. Y., C. M. Carthy, D. Granville, D. W. C. Hunt and J. Piette Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization. Oncogene. 20. 4070-4084.
43. Imbert, V., R. A. Rupec, A. Livolsi, H. L. Pahl, E. B. Traenckner, C. Mueller-Dieckmann, D. Farahifar, B. Rossi, P. Auberger, P. A. Baeuerle and J. F. Peyron (1996) Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell 86, 787-798.
44. Beraud, C., W. J. Henzel and P. A. Baeuerle (1999) Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. Proc. Natl. Acad. Sci. USA 96, 429-434.
45. Mukhopadhyay, A., S. K. Manna and B. B. Aggarwal (2000) Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha. J. Biol. Chem. 275, 8549-8555.
46. Li, N. and M. Karin (1998) Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA 95, 13012-13017.
47. Bender, K., M. Gottlicher, S. Whiteside, H. J. Rahmsdorf and P. Herrlich (1998) Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV. EMBO J. 17, 5170-5181.
48. Delhase, M., M. Hayakawa, Y. Chen and M. Karin (1999) Positive and negative regulation of 1kappaB kinase activity through IKKbeta subunit phosphorylation. Science 284, 309-313.
49. Rossi, A., P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin and M. G. Santoro (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403, 103-108.